Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | STATINS | authKW | 1532502 | 15% | 34% | 2571 |
2 | EZETIMIBE | authKW | 691670 | 3% | 68% | 568 |
3 | SIMVASTATIN | authKW | 472461 | 4% | 35% | 760 |
4 | HMG COA REDUCTASE INHIBITORS | authKW | 430113 | 3% | 48% | 503 |
5 | ATORVASTATIN | authKW | 415267 | 4% | 35% | 665 |
6 | PCSK9 | authKW | 393088 | 2% | 75% | 295 |
7 | PRAVASTATIN | authKW | 295566 | 2% | 46% | 358 |
8 | ROSUVASTATIN | authKW | 287488 | 2% | 48% | 340 |
9 | HYPERCHOLESTEROLEMIA | authKW | 218070 | 4% | 18% | 682 |
10 | NIACIN | authKW | 205888 | 2% | 40% | 290 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 74433 | 26% | 1% | 4608 |
2 | Pharmacology & Pharmacy | 30736 | 26% | 0% | 4557 |
3 | Peripheral Vascular Diseases | 21333 | 11% | 1% | 1902 |
4 | Medicine, General & Internal | 20665 | 17% | 0% | 2992 |
5 | Endocrinology & Metabolism | 2637 | 6% | 0% | 1047 |
6 | Primary Health Care | 2199 | 1% | 1% | 213 |
7 | Medicine, Research & Experimental | 1769 | 5% | 0% | 877 |
8 | Health Care Sciences & Services | 975 | 2% | 0% | 361 |
9 | Health Policy & Services | 402 | 1% | 0% | 187 |
10 | Toxicology | 389 | 2% | 0% | 393 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL PHARMACOKINET | 49582 | 0% | 37% | 76 |
2 | INTERNAL MED CLIN PHARMACOL | 32294 | 0% | 31% | 58 |
3 | CARDIOL | 31026 | 10% | 1% | 1767 |
4 | LIPID CLIN | 24712 | 1% | 16% | 90 |
5 | OFF HLTH PROMOT DIS PREVENT | 21881 | 0% | 53% | 23 |
6 | POINT MED | 20929 | 0% | 59% | 20 |
7 | BIOCHEM NEUROENDOCRINOL | 20548 | 0% | 21% | 55 |
8 | CARDIOVASC DIS PREVENT | 18190 | 0% | 15% | 69 |
9 | RIKEN INNOVAT | 16233 | 0% | 42% | 22 |
10 | HEART DIS PREVENT CLIN | 15851 | 0% | 64% | 14 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL LIPIDOLOGY | 59704 | 1% | 21% | 157 |
2 | ATHEROSCLEROSIS | 41607 | 3% | 5% | 507 |
3 | AMERICAN JOURNAL OF CARDIOLOGY | 35300 | 4% | 3% | 741 |
4 | CURRENT OPINION IN LIPIDOLOGY | 28628 | 1% | 11% | 149 |
5 | ATHEROSCLEROSIS SUPPLEMENTS | 24086 | 0% | 22% | 62 |
6 | CURRENT ATHEROSCLEROSIS REPORTS | 17281 | 0% | 12% | 82 |
7 | AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 16907 | 0% | 15% | 65 |
8 | EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 14263 | 0% | 10% | 83 |
9 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 13038 | 0% | 9% | 85 |
10 | CURRENT MEDICAL RESEARCH AND OPINION | 12518 | 1% | 4% | 182 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STATINS | 1532502 | 15% | 34% | 2571 | Search STATINS | Search STATINS |
2 | EZETIMIBE | 691670 | 3% | 68% | 568 | Search EZETIMIBE | Search EZETIMIBE |
3 | SIMVASTATIN | 472461 | 4% | 35% | 760 | Search SIMVASTATIN | Search SIMVASTATIN |
4 | HMG COA REDUCTASE INHIBITORS | 430113 | 3% | 48% | 503 | Search HMG+COA+REDUCTASE+INHIBITORS | Search HMG+COA+REDUCTASE+INHIBITORS |
5 | ATORVASTATIN | 415267 | 4% | 35% | 665 | Search ATORVASTATIN | Search ATORVASTATIN |
6 | PCSK9 | 393088 | 2% | 75% | 295 | Search PCSK9 | Search PCSK9 |
7 | PRAVASTATIN | 295566 | 2% | 46% | 358 | Search PRAVASTATIN | Search PRAVASTATIN |
8 | ROSUVASTATIN | 287488 | 2% | 48% | 340 | Search ROSUVASTATIN | Search ROSUVASTATIN |
9 | HYPERCHOLESTEROLEMIA | 218070 | 4% | 18% | 682 | Search HYPERCHOLESTEROLEMIA | Search HYPERCHOLESTEROLEMIA |
10 | NIACIN | 205888 | 2% | 40% | 290 | Search NIACIN | Search NIACIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |